🇺🇸 FDA
Patent

US 11021517

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery

granted A61KA61K38/1825A61K38/185

Quick answer

US patent 11021517 (Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery) held by The Regents of the University of California expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/1825, A61K38/185, A61K38/30, A61K41/0057